|  Help  |  About  |  Contact Us

Publication : miR-34b/c regulates doxorubicin-induced myocardial cell injury through ITCH.

First Author  Zhang WC Year  2019
Journal  Cell Cycle Volume  18
Issue  23 Pages  3263-3274
PubMed ID  31627713 Mgi Jnum  J:298394
Mgi Id  MGI:6480069 Doi  10.1080/15384101.2019.1673618
Citation  Zhang WC, et al. (2019) miR-34b/c regulates doxorubicin-induced myocardial cell injury through ITCH. Cell Cycle 18(23):3263-3274
abstractText  Objective: To determine the underlying mechanism of miR-34b/c in regulating doxorubicin (Dox)-induced myocardial cell injury.Methods: The viability of mouse myocardial cells HL-1 was detected by MTT assay. The apoptosis of HL-1 cells was detected by TUNEL assay. mRNA expressions of ITCH, TNF-alpha and IL-6 were measured by qRT-PCR. Protein levels of ITCH, NF-kappaB, TNF-alpha and IL-6 were measured by western blot. Dual luciferase assay was performed to detect the regulation of miR-34b/c on ITCH. Mouse model of cardiomyopathy was induced by intraperitoneal injection of Dox.Results: Dox reduced HL-1 cell viability and activated NF-kappaB pathway in HL-1 cells. miR-34b/c expressions were gradually up-regulated and ITCH expression was gradually down-regulated in Dox-treated HL-1 cells. miR-34b/c expression had negative correlation with the mRNA expression of ITCH. Besides, ITCH was a target of miR-34b/c. miR-34b/c mimic reduced cell viability, suppressed ITCH expression, increased TNF-alpha and IL-6 level, and promoted NF-kappaB expression in nucleus and cytoplasm of HL-1 cells. Whereas silencing miR-34 protected HL-1 cells through regulating ITCH. Finally, we demonstrated miR-34 antagomir-protected myocardial cells in mouse model of cardiomyopathy.Conclusion: miR-34b/c decreased HL-1 cell viability and promoted the secretion of proinflammatory cytokines in Dox-induced myocardial cells through ITCH/NF-kappaB pathway.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

2 Bio Entities

0 Expression